Inner ear implant aims to restore balance in dizzy patients

NCT ID NCT05674786

First seen Jan 12, 2026

Summary

This study tests a vestibular implant, a device surgically placed in the inner ear to electrically stimulate balance nerves. It aims to improve balance, posture, and vision in up to 8 adults with bilateral vestibular hypofunction, a condition causing chronic dizziness and instability. Participants receive the implant and are evaluated over 6 months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VESTIBULAR DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Johns Hopkins School of Medicine

    RECRUITING

    Baltimore, Maryland, 21287, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Vestibular implant (MVI™ Multichannel Vestibular Implant System)

What this could lead to

If successful, this could lead to an effective treatment for chronic imbalance and unsteady vision in people with bilateral vestibular hypofunction.

What could go wrong

This is a very small early study with only 8 participants, so results may not apply to everyone. The implant is experimental and carries surgical risks.

Conditions

The condition(s) this trial relates to.

bilateral hypoactive labyrinth Bilateral Vestibulopathy cerebellar ataxia, intellectual disability, and dysequilibrium deafness, aminoglycoside-induced Dizziness idiopathic bilateral vestibulopathy inner ear disorder Ototoxicity Sensation Disorders vestibular disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.